|
| Exchange Disseminated Time 25/10/2016 15:04:55 | Jyothy Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 25, 2016 at 11.30 a.m. and concluded at 1.30 p.m inter alia, have :
1. Approved re-appointment of Mr. K. Ullas Kamath designated as Joint Managing Director & Chief Financial Officer for a period of 5 years, subject to approval of the Shareholders of the Company;
2. Approved re-appointment of Ms. M. R. Jyothy designated as Whole Time Director & Chief Marketing Officer for a period of 5 years, subject to approval of the Shareholders of the Company;
3. Approved raising of funds upto Rs. 500 Crores through issuance of fresh non-convertible debentures on private placement basis subject to approval of the Shareholders of the Company and redemption of 4000 Zero Coupon, Secured, Redeemable Non-Convertible Debentures aggregating to Rs. 400 Crores. |
|
|